MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3

被引:81
|
作者
Bai, Xiangdong [1 ,3 ]
Han, Guohui [3 ]
Liu, Yang [3 ]
Jiang, Hongchuan [2 ]
He, Qiang [1 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hepatobiliary Surg, Affiliated Hosp, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chaoyang Hosp, Dept Breast Surg, Affiliated Hosp, Beijing, Peoples R China
[3] Shanxi Med Univ, Shanxi Prov Canc Hosp, Dept Breast Surg, Taiyuan, Shanxi, Peoples R China
关键词
miR-20a-5p; Triple-negative breast cancer; RUNX3; Cell proliferation; MIR-20A; METASTASIS; INVASION; EXPRESSION; AUTOPHAGY;
D O I
10.1016/j.biopha.2018.04.165
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Increasing evidence showed that microRNAs (miRNAs) were abnormally expressed in cancers and made effects on the tumorigenesis. Aberrant expression of miR-20a-5p has been reported in human breast carcinoma. However, the functional mechanism of miR-20a-5p in human breast carcinoma, particularly in triple-negative breast cancer (TNBC), required further investigations. Here, firstly, we determined that miR-20a-5p was highly expressed in both TNBC tissues and cell lines. Then, we explored that the overexpression of miR-20a-5p promoted the migration and invasion of TNBC cells in vitro. The tendency was significantly reversed after the depletion of miR-20a-5p. Consistent result could be obtained with the in vivo nude mice tumorigenesis. Thirdly, the underlying molecular mechanism was investigated. The Runt-related transcription factor 3 (RUNX3) was identified as a target of miR-20a-5p in TNBC cells. High expression of miR-20a-5p significantly decreased both the mRNA and protein levels of RUNX3, as well as its direct downstream targets Bim and p21. These results verified the significance of miR-20a-5p and explored its functional mechanisms in TNBC, suggesting the potential clinical applications of miR-20a-5p in TNBC.
引用
收藏
页码:1482 / 1489
页数:8
相关论文
共 50 条
  • [41] Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
    Kong, W.
    He, L.
    Richards, E. J.
    Challa, S.
    Xu, C-X
    Permuth-Wey, J.
    Lancaster, J. M.
    Coppola, D.
    Sellers, T. A.
    Djeu, J. Y.
    Cheng, J. Q.
    ONCOGENE, 2014, 33 (06) : 679 - 689
  • [42] Cadmium promotes the proliferation of triple-negative breast cancer cells through EGFR-mediated cell cycle regulation
    Wei, Zhengxi
    Song, Xiulong
    Shaikh, Zahir A.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2015, 289 (01) : 98 - 108
  • [43] AQP5 promotes epithelial-mesenchymal transition and tumor growth through activating the Wnt/(3-catenin pathway in triple-negative breast cancer
    Zhu, Zhengcai
    Li, Tao
    Wang, Honggang
    Jiao, Lianghe
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2024, 829 : 111868
  • [44] Research on the effect of interfering with miRNA-155 on triple-negative breast cancer cells
    Hu, Yangying
    Wu, Deqi
    Feng, Xiangjun
    Shi, Zhijie
    GENES & GENOMICS, 2022, 44 (09) : 1117 - 1124
  • [45] Research on the effect of interfering with miRNA-155 on triple-negative breast cancer cells
    Yangying Hu
    Deqi Wu
    Xiangjun Feng
    Zhijie Shi
    Genes & Genomics, 2022, 44 : 1117 - 1124
  • [46] CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
    Zhou, Ru
    Yazdanifar, Mahboubeh
    Das Roy, Lopamudra
    Whilding, Lynsey M.
    Gavrill, Artemis
    Maher, John
    Mukherjee, Pinku
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [47] Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
    Tate, Chandra R.
    Rhodes, Lyndsay V.
    Segar, H. Chris
    Driver, Jennifer L.
    Pounder, F. Nell
    Burow, Matthew E.
    Collins-Burow, Bridgette M.
    BREAST CANCER RESEARCH, 2012, 14 (03)
  • [48] MicroRNA-17 acts as a tumor Chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer
    Wang, Sumei
    Oh, Do-Youn
    Leventaki, Vasiliki
    Drakos, Elias
    Zhang, Ronghua
    Sahin, Aysegul A.
    Resetkova, Erika
    Edgerton, Mary Elizabeth
    Wu, Wanyin
    Claret, Francois X.
    CANCER LETTERS, 2019, 465 : 12 - 23
  • [49] miR-155-5p antagonizes the apoptotic effect of bufalin in triple-negative breast cancer cells
    Wang, Qian
    Li, Ce
    Zhu, Zhitu
    Teng, Yuee
    Che, Xiaofang
    Wang, Yan
    Ma, Yanju
    Wang, Yiding
    Zheng, Huachuan
    Liu, Yunpeng
    Qu, Xiujuan
    ANTI-CANCER DRUGS, 2016, 27 (01) : 9 - 16
  • [50] Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
    Chandra R Tate
    Lyndsay V Rhodes
    H Chris Segar
    Jennifer L Driver
    F Nell Pounder
    Matthew E Burow
    Bridgette M Collins-Burow
    Breast Cancer Research, 14